New Cancer Immunology Discovery Highlights Future Opportunities for ABBIE™
A recent study by researchers at the University of Oxford, published in Science Immunology and reported by MedicalXpress, has revealed […]
Blog
ABBIE
Anito-cel CAR-T Shows Breakthrough Results in Multiple Myeloma and What That Means for Next-Gen Manufacturing with ABBIE
Recent data presented at the 2025 American Society of Hematology (ASH) meeting and reported in medical press have confirmed that
ABBIE-Enabled CAR-T Manufacturing: Expanding Toward Neurological Diseases Like Multiple Sclerosis and Alzheimer’s
CAR-T cell therapy has already reshaped cancer treatment by enabling a patient’s own T cells to recognize and destroy malignant
SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery.
CHINO HILLS, CALIFORNIA / ACCESS Newswire / November 6, 2025 / SOHM, Inc. (OTCID:SHMN), a pharmaceutical and biotechnology company specializing in
SOHM Notes FDA’s Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development.
CHINO HILLS, CALIFORNIA / ACCESS Newswire / November 4, 2025 / SOHM, Inc. (OTCID:SHMN), a pharmaceutical and biotechnology company specializing in
ABBIE and the Future of Cancer Research
Our cells rely on glycogen — a stored form of sugar — to keep up with energy demands. An enzyme